Back
•
Overview
•
In the News
•
Press Releases
•
Email Alert
In the News
Avicena Receives Patents for its Nurigene Skin Care Regimen
Dr. Belinda Tsao-Nivaggioli Presents a Corporate Overview During the BIO CEO & Investor Conference
Dr. Belinda Tsao Nivaggioli discusses Avicena Group with WallSt.net
Avicena in BioWorld Today
-
Avicena Drug Misses Endpoint But Shows Improved Mortality
Boost Your Brain Power: Creatine Found To Improve Working Memory And General Intelligence
Creatine and Minocycline as Treatment Against ALS
Avicena Wants to Market Creatine as Orphan Drug
Drug Prescribed for Acne May Slow Progress of ALS
©2008 Avicena® Group |
info@avicenagroup.com
|
Privacy Policy
|
Site Credits